MedTrace Logo

Morphine Added to Ropivacaine for FICB for Postoperative Analgesia

NCT03875274 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2023-03-24

Study results available
· View outcomes & findings →

Summary

prospective, randomized double blinded study to investigate the effects of morphine as an adjuvant to ropivacaine on FICB

Conditions

  • Postoperative Pain

Interventions

DRUG

Ropivacaine, Morphine

Morphine added to ropivacaine for fascia iliaca compartment block

DRUG

Ropivacaine, Saline

Normal saline added to ropivacaine for fascia iliaca compartment block

Sponsors & Collaborators

  • B.P. Koirala Institute of Health Sciences

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-01
Primary Completion
2017-12-31
Completion
2017-12-31

Countries

  • Nepal

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03875274 on ClinicalTrials.gov